6-162054135-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004562.3(PRKN):​c.574A>C​(p.Met192Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0033 in 1,613,726 control chromosomes in the GnomAD database, including 138 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 60 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 78 hom. )

Consequence

PRKN
NM_004562.3 missense

Scores

1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.78

Publications

20 publications found
Variant links:
Genes affected
PRKN (HGNC:8607): (parkin RBR E3 ubiquitin protein ligase) The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. [provided by RefSeq, Jul 2008]
PRKN Gene-Disease associations (from GenCC):
  • autosomal recessive juvenile Parkinson disease 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003251642).
BP6
Variant 6-162054135-T-G is Benign according to our data. Variant chr6-162054135-T-G is described in ClinVar as Benign. ClinVar VariationId is 415531.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0579 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKNNM_004562.3 linkc.574A>C p.Met192Leu missense_variant Exon 5 of 12 ENST00000366898.6 NP_004553.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKNENST00000366898.6 linkc.574A>C p.Met192Leu missense_variant Exon 5 of 12 1 NM_004562.3 ENSP00000355865.1

Frequencies

GnomAD3 genomes
AF:
0.0171
AC:
2601
AN:
152118
Hom.:
59
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0598
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00498
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.0119
GnomAD2 exomes
AF:
0.00442
AC:
1111
AN:
251356
AF XY:
0.00328
show subpopulations
Gnomad AFR exome
AF:
0.0599
Gnomad AMR exome
AF:
0.00237
Gnomad ASJ exome
AF:
0.000596
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00186
AC:
2713
AN:
1461490
Hom.:
78
Cov.:
30
AF XY:
0.00163
AC XY:
1184
AN XY:
727068
show subpopulations
African (AFR)
AF:
0.0626
AC:
2096
AN:
33472
American (AMR)
AF:
0.00318
AC:
142
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000651
AC:
17
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00382
AC:
22
AN:
5766
European-Non Finnish (NFE)
AF:
0.000126
AC:
140
AN:
1111644
Other (OTH)
AF:
0.00465
AC:
281
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
130
260
391
521
651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0171
AC:
2609
AN:
152236
Hom.:
60
Cov.:
32
AF XY:
0.0170
AC XY:
1262
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0598
AC:
2483
AN:
41510
American (AMR)
AF:
0.00497
AC:
76
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68024
Other (OTH)
AF:
0.0118
AC:
25
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
118
237
355
474
592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00819
Hom.:
93
Bravo
AF:
0.0192
ESP6500AA
AF:
0.0572
AC:
252
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00540
AC:
656
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 28, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Apr 12, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive juvenile Parkinson disease 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
0.040
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.10
T;.;.;T
Eigen
Benign
-0.064
Eigen_PC
Benign
0.11
LIST_S2
Benign
0.68
T;.;D;T
MetaRNN
Benign
0.0027
T;T;T;T
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
0.0
.;.;.;.
PhyloP100
2.8
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.030
N;N;N;N
Sift
Benign
0.055
T;T;T;D
Sift4G
Benign
0.084
T;T;T;T
Vest4
0.27
ClinPred
0.025
T
GERP RS
5.4
Varity_R
0.29
gMVP
0.23
Mutation Taster
=53/111
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9456735; hg19: chr6-162475167; API